Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Bio-Path Holdings (NQ: BPTH )

6.670 USD +0.400 (+6.38%)
Streaming Delayed Price Updated: 12:11 PM EDT, Apr 13, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 178,323
Open 6.280
Bid (Size) 6.620 (2)
Ask (Size) 6.670 (3)
Prev. Close 6.270
Today's Range 6.250 - 6.700
52wk Range 3.120 - 24.34
Shares Outstanding 11,340,756
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Bio-Path Holdings Presents BP1002 Data at 2021 American Association for Cancer Research Annual Meeting
Preclinical Data Support BP1002 Combination Therapy in Venetoclax-resistant AML Patients 
From GlobeNewswire News Releases
Bio-Path Holdings Announces Successful Completion of Safety Cohort of Triple Combination of Prexigebersen, Decitabine and Venetoclax in Stage 2 of Phase 2 Clinical Trial in Acute Myeloid Leukemia
From GlobeNewswire News Releases

Performance

YTD
+83.75%
+83.75%
1 Month
-11.07%
-11.07%
3 Month
+64.69%
+64.69%
6 Month
+54.76%
+54.76%
1 Year
+29.01%
+29.01%

More News

Read More
Bio-Path Holdings to Present at the 2021 American Association for Cancer Research Annual Meeting
From GlobeNewswire News Releases
Bio-Path Holdings Reports Full Year 2020 Financial Results
From GlobeNewswire News Releases
Bio-Path Holdings to Announce Full Year 2020 Financial Results on March 10, 2021
From GlobeNewswire News Releases
BioMedNewsBreaks – Bio-Path Holdings Inc. (NASDAQ: BPTH) Secures $13M in Public Offering
From InvestorBrandNetwork
Bio-Path Holdings, Inc. Announces Closing of $13.0 Million Public Offering of Common Stock
From GlobeNewswire News Releases
12 Health Care Stocks Moving In Monday's Intraday Session
Tags EARS CEMI HTGM
From Benzinga
Why Acadia Pharma, Bio-path And Cidara Are Moving Today
Tags CDTX Biotech Movers
From Benzinga
Thinking about buying stock in Castor Maritime, Zomedica, AMC Entertainment, Palantir Technologies, or Bio-Path Holdings?
From PR Newswire
Bio-Path Stock Is Trading Higher As Prexigebersen Triplet Combo Shows Favorable Safety Profile In Acute Myeloid Leukemia Study
Tags Biotech Market News FDA
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.